What Researchers Did
Researchers conducted a retrospective study on 75 patients with idiopathic sudden sensorineural hearing loss (ISSNHL) to evaluate the effectiveness of intratympanic dexamethasone or hyperbaric oxygen therapy as salvage treatments in addition to systemic steroids.
What They Found
The study initially included 75 patients, with 62 (31 men and 31 women, mean age 56 years) definitively enrolled after primary systemic steroid treatment failed. Patients were divided into three groups: systemic steroids alone, systemic steroids plus hyperbaric oxygen therapy, or systemic steroids plus intratympanic steroids, with hearing recovery assessed at 3 months.
What This Means for Canadian Patients
For Canadian patients experiencing ISSNHL, this research explores additional treatment options if initial steroid therapy is insufficient. It suggests that intratympanic steroids or hyperbaric oxygen therapy might be considered as salvage treatments to improve hearing outcomes.
Canadian Relevance
This study has no direct Canadian connection as it was conducted in a non-Canadian hospital.
Study Limitations
A key limitation of this study is its retrospective design, which may introduce biases and limit the generalizability of the findings.